As of 2024-12-14, the Intrinsic Value of Spire Healthcare Group PLC (SPI.L) is
317.26 GBP. This SPI.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 228.50 GBP, the upside of Spire Healthcare Group PLC is
38.80%.
The range of the Intrinsic Value is 109.44 - 1,037.85 GBP
317.26 GBP
Intrinsic Value
SPI.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
109.44 - 1,037.85 |
317.26 |
38.8% |
| DCF (Growth 10y) |
210.98 - 1,302.21 |
457.38 |
100.2% |
| DCF (EBITDA 5y) |
109.69 - 220.42 |
163.97 |
-28.2% |
| DCF (EBITDA 10y) |
201.71 - 395.25 |
291.10 |
27.4% |
| Fair Value |
177.60 - 177.60 |
177.60 |
-22.28% |
| P/E |
107.98 - 158.96 |
132.80 |
-41.9% |
| EV/EBITDA |
87.39 - 316.63 |
215.53 |
-5.7% |
| EPV |
816.51 - 1,397.51 |
1,107.01 |
384.5% |
| DDM - Stable |
63.76 - 190.99 |
127.38 |
-44.3% |
| DDM - Multi |
94.77 - 214.83 |
130.87 |
-42.7% |
SPI.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
910.29 |
| Beta |
0.73 |
| Outstanding shares (mil) |
3.98 |
| Enterprise Value (mil) |
2,119.49 |
| Market risk premium |
5.98% |
| Cost of Equity |
9.07% |
| Cost of Debt |
9.89% |
| WACC |
8.46% |